tradingkey.logo

TruBridge Inc

TBRG

21.410USD

+0.580+2.78%
Close 09/18, 16:00ETQuotes delayed by 15 min
321.47MMarket Cap
LossP/E TTM

TruBridge Inc

21.410

+0.580+2.78%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated2025-09-17

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
55 / 207
Overall Ranking
175 / 4723
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
24.750
Target Price
+19.28%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company operates through three segments: RCM, HER and Patient Engagement. The RCM segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics and business intelligence. The EHR segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Engagement segment offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its wholly owned subsidiaries include Viewgol, LLC, iNetXperts, Corp. doing business as Get Real Health, Healthcare Resource Group, Inc. and Healthland Holding Inc.
Undervalued
The company’s latest PE is -27.75, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 13.07M shares, decreasing 23.72% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 750.49K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.29.

Financial Health

Currency: USD Updated2025-09-17

The company's current financial score is 7.53, which is higher than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 85.73M, representing a year-over-year increase of 1.18%, while its net profit experienced a year-over-year increase of 151.62%.

Score

Industry at a Glance

Previous score
7.53
Change
0

Financials

5.76

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

9.85

Operational Efficiency

8.52

Growth Potential

6.36

Shareholder Returns

7.15

Company Valuation

Currency: USD Updated2025-09-17

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is -27.75, which is -179.72% below the recent high of 22.12 and 36.82% above the recent low of -17.53.

Score

Industry at a Glance

Previous score
2.00
Change
-0.8

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 55/207
No Data

Earnings Forecast

Currency: USD Updated2025-09-17

The company’s current earnings forecast score is 7.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for TruBridge Inc is 25.50, with a high of 28.00 and a low of 20.00.

Score

Industry at a Glance

Previous score
7.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts
Buy
Current Rating
24.750
Target Price
+18.82%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

94
Total
4
Median
7
Average
Company name
Ratings
Analysts
TruBridge Inc
TBRG
4
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated2025-09-17

The company’s current price momentum score is 8.88, which is higher than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 21.65 and the support level at 19.64, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
8.87
Change
0.01

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.411
Neutral
RSI(14)
62.019
Neutral
STOCH(KDJ)(9,3,3)
79.813
Buy
ATR(14)
0.589
High Vlolatility
CCI(14)
229.954
Overbought
Williams %R
11.940
Overbought
TRIX(12,20)
0.019
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
20.684
Buy
MA10
20.385
Buy
MA20
20.203
Buy
MA50
20.785
Buy
MA100
22.456
Sell
MA200
23.333
Sell

Institutional Confidence

Currency: USD Updated2025-09-17

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 87.01%, representing a quarter-over-quarter increase of 2.01%. The largest institutional shareholder is The Vanguard, holding a total of 750.49K shares, representing 5.00% of shares outstanding, with 15.13% increase in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Pinetree Capital Ltd.
2.67M
+2.70%
Ocho Investments, L.L.C.
1.11M
--
Rorema Beheer B.V.
760.46K
--
The Vanguard Group, Inc.
Star Investors
663.86K
+2.58%
Nellore Capital Management LLC
216.91K
--
BlackRock Institutional Trust Company, N.A.
253.19K
-3.90%
Dimensional Fund Advisors, L.P.
345.50K
-0.99%
Martin & Company Investment Counsel
384.71K
-22.93%
Federated MDTA LLC
456.71K
-1.80%
Columbia Threadneedle Investments (US)
448.96K
-7.69%
1
2

Risk Assessment

Currency: USD Updated2025-09-17

The company’s current risk assessment score is 4.68, which is higher than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.58. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
4.68
Change
0
Beta vs S&P 500 index
0.58
VaR
+3.68%
240-Day Maximum Drawdown
+37.16%
240-Day Volatility
+50.54%
Return
Best Daily Return
60 days
+3.91%
120 days
+7.79%
5 years
+24.46%
Worst Daily Return
60 days
-10.76%
120 days
-10.76%
5 years
-19.66%
Sharpe Ratio
60 days
-0.58
120 days
-1.63
5 years
+0.06
Risk Assessment
Maximum Drawdown
240 days
+37.16%
3 years
+76.15%
5 years
+79.46%
Return-to-Drawdown Ratio
240 days
+2.02
3 years
-0.15
5 years
-0.06
Skewness
240 days
+0.02
3 years
-0.32
5 years
-0.43
Volatility
Realised Volatility
240 days
+50.54%
5 years
+45.03%
Standardised True Range
240 days
+4.58%
5 years
+4.02%
Downside Risk-Adjusted Return
120 days
-206.72%
240 days
-206.72%
Maximum Daily Upside Volatility
60 days
+23.17%
Maximum Daily Downside Volatility
60 days
+37.56%
Liquidity
Average Turnover Rate
60 days
+1.07%
120 days
+1.10%
5 years
--
Turnover Deviation
20 days
-28.62%
60 days
+3.09%
120 days
+5.69%

Peer Comparison

Healthcare Equipment & Supplies
TruBridge Inc
TruBridge Inc
TBRG
6.41 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
7.91 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
7.86 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
Stevanato Group SpA
STVN
7.84 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Abbott Laboratories
Abbott Laboratories
ABT
7.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Transmedics Group Inc
Transmedics Group Inc
TMDX
7.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI